Clinical trial
eHealth-based Bavarian Alternative Detection of Atrial Fibrillation: A Randomized Controlled Trial (eBRAVE-AF)
NCT04250220 is registered in ClinicalTrials.gov with LMU Klinikum as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- eHealth-based Bavarian Alternative Detection of Atrial Fibrillation: A Randomized Controlled Trial (eBRAVE-AF)
- Lead sponsor
- LMU Klinikum
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 3, 2020
- Completion date
- July 31, 2021
- Enrollment
- 4,400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.